Stockscreener 앱 받기
7.56
0.66%
-0.05
시간 외 거래:
7.60
0.04
+0.53%
전일 마감가:
$7.61
열려 있는:
$7.62
하루 거래량:
22,001
Relative Volume:
0.84
시가총액:
$51.27M
수익:
-
순이익/손실:
$-71.37M
주가수익비율:
-0.7014
EPS:
-10.7782
순현금흐름:
$-46.62M
1주 성능:
-5.26%
1개월 성능:
-6.32%
6개월 성능:
-31.34%
1년 성능:
-72.85%
1일 변동 폭
$7.555
$7.76
1주일 범위
$7.555
$8.06
52주 변동 폭
$5.67
$33.83
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
Compare TIL vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
7.56 | 53.71M | 0 | -71.37M | -46.62M | -10.78 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2026-01-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-04-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
| 2021-08-13 | 개시 | Robert W. Baird | Outperform |
| 2021-04-13 | 개시 | Cowen | Outperform |
| 2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
Instil Bio (TIL) director awarded stock options for 6,500 shares at $7.93 - Stock Titan
Instil Bio (NASDAQ: TIL) director receives grant of 6,500 stock options - Stock Titan
Instil Bio (TIL) director awarded 6,500 stock options at $7.93 strike - Stock Titan
Instil Bio (TIL) director Gwendolyn Binder awarded 6,500 stock options at $7.93 - Stock Titan
Instil Bio Shareholders Back Directors and Auditor at Meeting - TipRanks
[8-K] Instil Bio, Inc. Reports Material Event - Stock Titan
Instil Bio Inc. (TIL) Edges Lower as Stock Tests Key Support ZoneWave Truncation - newsline.com
Instil Bio Inc. Q1 2026 Earnings: EPS Misses Estimates Amid No RevenueBasic EPS Analysis - newsline.com
TIL Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued R&D Investment Amid No RevenueEPS Growth Rate - newsline.com
(TIL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TIL Technical Analysis | Trend, Signals & Chart Patterns | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
How (TIL) Movements Inform Risk Allocation Models - Stock Traders Daily
TIL News | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
TIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Early-Stage Development ChallengesCapex Guidance - The Legal Advocate
Instil Bio Inc. (TIL) Holds Steady Near Key Support After Modest UptickShort Setup Alerts - The Legal Advocate
Instil Bio Q1 2026 Earnings: EPS Miss as Development-Stage Company Reports No Revenue; Stock Edges UpROA Comparison - The Legal Advocate
Instil Bio Q1 2026 Earnings: EPS Miss Reflects Ongoing R&D InvestmentFinancial Health Score - The Legal Advocate
Instil Bio Inc. (TIL) Q1 2026 Earnings: Wider-Than-Expected Loss as Biotech Continues Pre-Commercial PhaseFree Market Insights - Newser
Instil Bio (TIL) Q1 2026 Results Fall Short — EPS $-0.62, Revenue $N/AStock Idea Network - Newser
Trading Systems Reacting to (TIL) Volatility - Stock Traders Daily
Instil Bio (TIL) Q4 2025 Beat: Revenue $N/A, EPS Exceeds by SignificantMargin Improvement - Newser
Instil Bio Releases Q1 2026 Financial Results - AlphaStreet
Instil Bio, Inc. Reports First Quarter 2026 Financial Results – 8-K Filing Details and Key Highlights - Minichart
Instil Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Instil Bio, Inc. 1Q 2026: Net loss $4.2M, EPS $(0.62) — 10-Q Summary - TradingView
Instil Bio (NASDAQ: TIL) cuts Q1 loss as 2024 loan and going concern risk loom - Stock Titan
Instil Bio (Nasdaq: TIL) trims Q1 2026 loss and extends cash runway beyond 2027 - Stock Titan
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
BRIEF-Instil Bio Q1 Basic EPS USD -0.62 - TradingView
TradingKey - TradingKey
MSN Money - MSN
Why Instil Bio (TIL) deserves a deeper look right now (Smart Money Flows) 2026-05-08AI Powered Stock Picks - Newser
Instil Bio Inc expected to post a loss of 59 cents a shareEarnings Preview - TradingView
How Instil Bio Inc. (TIL) Affects Rotational Strategy Timing - Stock Traders Daily
The R&D spending story behind Instil Bio (TIL) innovation | Instil Bio posts 41% EPS beat, narrower loss, no revenueDebt/EBITDA - newser.com
Instil Bio posts 41% EPS beat, narrower loss, no revenueFinal Results - The Legal Advocate
Key Growth Drivers | Instil Bio posts 40.9% EPS beat topping analyst estimatesConsensus Forecast - newser.com
Instil Bio (TIL) Stock: Key Growth Drivers | Instil Bio posts 40.9% EPS beat topping analyst estimatesFast Rising Picks - Newser
(TIL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
[ARS] Instil Bio, Inc. SEC Filing - Stock Titan
Instil Bio (NASDAQ: TIL) sets 2026 vote and replaces Deloitte - Stock Titan
TIL Instil Bio delivers strong Q4 2025 EPS upside versus analyst estimates, shares edge slightly higher in today’s session.Market Expert Watchlist - Newser
TIL (Instil Bio Inc.) posts narrower Q4 2025 loss than consensus estimates, shares dip modestly in muted market reaction.Viral Trade Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Instil Bio, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
TIL Ownership | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
Instil Bio (TIL) Stock Wall Street Rating (+0.11%) 2026-04-16Community Trade Ideas - Xã Thanh Hà
Responsive Playbooks and the TIL Inflection - Stock Traders Daily
Instil Bio (TIL) Price Target Increased by 24.53% to 67.32 - MSN
Breakout Move: Is Instil Bio Inc gaining market share2026 Setups & Community Verified Watchlist Alerts - baoquankhu1.vn
Will Instil Bio (TIL) Stock Outperform S&P 500 | Price at $7.99, Down 0.50%Earnings Beat Stocks - The Legal Advocate
Instil Bio appoints RSM US as new auditor, replacing Deloitte & Touche - Investing.com India
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
인스틸 바이오 주식 (TIL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO |
Sep 10 '25 |
Sale |
23.39 |
30,000 |
701,667 |
0 |
2.60%
0.94%
자본화:
|
볼륨(24시간):